In October, Dr Annabel Sowemimo joined us on the Wellcome Genome Campus to speak about her work exploring the ways that racism and colonial thinking are embedded within medicine, science and institutions – and the difficulties of untangling it.
We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.
Histologists, cardiologists, immunologists, cell biologists, software developers, bioinformaticians and specialist technicians have worked together to see individual cells in unprecedented detail. Using spatial genomics, they located each cell to its precise location in the heart.